Febuxostat non ritarda la progressione dell'aterosclerosi carotidea in pazienti con iperuricemia asintomatica: uno studio randomizzato e controllato
Aug 08, 2023
Caricamento delle metriche
Accesso libero
Revisionato da pari
ricerca articolo
Ruoli Concettualizzazione, Data Curation, Analisi formale, Investigazione, Metodologia, Amministrazione del progetto, Visualizzazione, Scrittura - bozza originale
* E-mail: [email protected] (AT); [email protected] (KN)
Affiliazione Dipartimento di Medicina Cardiovascolare, Università di Saga, Saga, Giappone
http://orcid.org/0000-0003-3352-7661
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Dipartimento di Cardiologia di affiliazione, Dokkyo Medical University Saitama Medical Center, Koshigaya, Giappone
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Dipartimento di affiliazione di medicina cardiovascolare, Ospedale JR Hiroshima, Hiroshima, Giappone
http://orcid.org/0000-0002-0183-2541
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Dipartimento di Cardiologia di affiliazione, Osaka Medical College, Takatsuki, Giappone
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Dipartimento di Cardiologia di affiliazione, Osaka Medical College, Takatsuki, Giappone
http://orcid.org/0000-0003-1228-1201
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Dipartimento di Cardiologia, Tokyo Medical University, Tokyo, Giappone
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Affiliazione Dipartimento di Medicina Cardiovascolare, Istituto di Scienze Biomediche, Tokushima University Graduate School, Tokushima, Giappone
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Affiliazione Dipartimento di Chirurgia Cardiovascolare, Scuola di Medicina dell'Università Nihon, Tokyo, Giappone
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Dipartimento di Medicina Interna, Hanyu General Hospital, Hanyu, Giappone
http://orcid.org/0000-0003-1841-6728
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Dipartimento di affiliazione della ricerca clinica, Organizzazione ospedaliera nazionale, Tochigi Medical Center, Utsunomiya, Giappone
http://orcid.org/0000-0001-8304-4516
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Affiliazione Dipartimento di Medicina Cardiovascolare, Dokkyo Medical University, Mibu, Giappone
http://orcid.org/0000-0002-8260-833X
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
Divisione di affiliazione di diabete, endocrinologia e metabolismo, Dipartimento di Medicina, Ospedale Kimitsu Chuo, Kisarazu, Giappone
http://orcid.org/0000-0003-2535-5396
Ruoli Concettualizzazione, Data Curation, Investigazione, Amministrazione del progetto, Supervisione, Scrittura - revisione e modifica
7.0 mg/dL) and maximum IMT of the common carotid artery (CCA) ≥1.1 mm at screening were allocated equally using a central web system to receive either dose-titrated febuxostat (10–60 mg daily) or as a control-arm, non-pharmacological lifestyle modification for hyperuricemia, such as a healthy diet and exercise therapy. Of the 514 enrolled participants, 31 were excluded from the analysis, with the remaining 483 people (mean age 69.1 years [standard deviation 10.4 years], female 19.7%) included in the primary analysis (febuxostat group, 239; control group, 244), based on a modified intention-to-treat principal. The carotid IMT images were recorded by a single sonographer at each site and read in a treatment-blinded manner by a single analyzer at a central core laboratory. The primary endpoint was the percentage change from baseline to 24 months in mean IMT of the CCA, determined by analysis of covariance using the allocation adjustment factors (age, gender, history of type 2 diabetes, baseline SUA, and baseline maximum IMT of the CCA) as the covariates. Key secondary endpoints included changes in other carotid ultrasonographic parameters and SUA and the incidence of clinical events. The mean values (± standard deviation) of CCA-IMT were 0.825 mm ± 0.173 mm in the febuxostat group and 0.832 mm ± 0.175 mm in the control group (mean between-group difference [febuxostat − control], −0.007 mm [95% confidence interval (CI) −0.039 mm to 0.024 mm; P = 0.65]) at baseline; 0.832 mm ± 0.182 mm in the febuxostat group and 0.848 mm ± 0.176 mm in the control group (mean between-group difference, −0.016 mm [95% CI −0.051 mm to 0.019 mm; P = 0.37]) at 24 months. Compared with the control group, febuxostat had no significant effect on the primary endpoint (mean percentage change 1.2% [95% CI −0.6% to 3.0%] in the febuxostat group (n = 207) versus 1.4% [95% CI −0.5% to 3.3%] in the control group (n = 193); mean between-group difference, −0.2% [95% CI −2.3% to 1.9%; P = 0.83]). Febuxostat also had no effect on the other carotid ultrasonographic parameters. The mean baseline values of SUA were comparable between the two groups (febuxostat, 7.76 mg/dL ± 0.98 mg/dL versus control, 7.73 mg/dL ± 1.04 mg/dL; mean between-group difference, 0.03 mg/dL [95% CI −0.15 mg/dL to 0.21 mg/dL; P = 0.75]). The mean value of SUA at 24 months was significantly lower in the febuxostat group than in the control group (febuxostat, 4.66 mg/dL ± 1.27 mg/dL versus control, 7.28 mg/dL ± 1.27 mg/dL; mean between-group difference, −2.62 mg/dL [95% CI −2.86 mg/dL to −2.38 mg/dL; P < 0.001]). Episodes of gout arthritis occurred only in the control group (4 patients [1.6%]). There were three deaths in the febuxostat group and seven in the control group during follow-up. A limitation of the study was the study design, as it was not a placebo-controlled trial, had a relatively small sample size and a short intervention period, and only enrolled Japanese patients with asymptomatic hyperuricemia./p>7.0 mg/dL and a maximum CCA-IMT ≥1.1 mm measured at eligibility assessment, defined as a carotid arterial plaque (localized protruding lesion) in accordance with the guidelines of the Japan Society of Ultrasonic in Medicine and the Japan Academy of Neurosonology [15]. Key exclusion criteria were the administration of any SUA-lowering agents within the 8-week period prior to assessment of eligibility, the presence of gouty tophus, or symptoms of gout arthritis within one year before assessment of eligibility./p>7.5-MHz linear transducer was performed at each site in a blinded manner by an expert, trained sonographer who had attended a lecture on acquiring images of the carotid IMT. All the imaging data were stored as JPEG files and then sent to the core imaging laboratory, where an expert analyzer measured the IMT values in a blinded manner using an automated IMT measurement software program (Vascular Research Tools 5, Medical Imaging Applications LLC, Coralville, IA) [18]./p>8.0 mg/dL) tended to have a greater percentage change in mean CCA-IMT, although the difference between the two groups was not statistically significant (strongS2 Fig/strong). Other carotid ultrasonographic values and their changes from baseline also did not differ between the treatment groups at any time point (strongTable 2/strong)./p>